SG3 Management, LLC - BEAM THERAPEUTICS INC ownership

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 230 filers reported holding BEAM THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.

Quarter-by-quarter ownership
SG3 Management, LLC ownership history of BEAM THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$31,288
-96.7%
800
-96.0%
0.01%
-92.3%
Q3 2022$952,400
+3.9%
20,000
+25.0%
0.06%
+150.0%
Q1 2022$917,000
-71.2%
16,000
-60.0%
0.03%
-59.4%
Q4 2021$3,188,000
-63.0%
40,000
-40.3%
0.06%
-79.1%
Q2 2021$8,624,000
-43.9%
67,000
-65.1%
0.31%
-20.3%
Q1 2021$15,368,000192,0000.38%
Other shareholders
BEAM THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
MWG Management Ltd. 2,362,635$189,105,00091.90%
PATHWAY CAPITAL MANAGEMENT, LP 37,399$2,993,00016.59%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 224,390$17,960,00010.54%
HSG Holding Ltd 796,089$63,719,0004.73%
DC Investments Management, LLC 21,010$1,682,0004.17%
Monashee Investment Management LLC 268,820$21,516,0003.31%
Redmile Group, LLC 2,532,523$202,703,0002.86%
HAMILTON LANE ADVISORS LLC 98,761$7,905,0002.58%
Alphabet Inc. 640,792$51,289,0002.07%
Casdin Capital, LLC 818,820$65,538,0001.95%
View complete list of BEAM THERAPEUTICS INC shareholders